Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the effects of non-absorbable disaccharides (lactulose and lactitol) in patients with hepatic encephalopathy. DATA SOURCES: Cochrane Hepato-Biliary Group controlled trials register, Cochrane Library, Medline, and Embase until March 2003; reference lists of relevant articles; authors and pharmaceutical companies. REVIEW METHODS: Randomised trials that compared non-absorbable disaccharides with placebo, no intervention, or antibiotics for hepatic encephalopathy were included. The primary outcome measures were no improvement of hepatic encephalopathy and all cause mortality. RESULTS: 22 trials were included. Compared with placebo or no intervention, non-absorbable disaccharides seemed to reduce the risk of no improvement in patients with hepatic encephalopathy (relative risk 0.62, 95% confidence interval 0.46 to 0.84, six trials). However, high quality trials found no significant effect (0.92, 0.42 to 2.04, two trials). Compared with placebo or no intervention, non-absorbable disaccharides had no significant effect on mortality (0.41, 0.02 to 8.68, four trials). Non-absorbable disaccharides were inferior to antibiotics in reducing the risk of no improvement (1.24, 1.02 to 1.50, 10 trials) and lowering blood ammonia concentration (weighted mean difference 2.35 micromol/l, 0.06 micromol/l to 13.45 micromol/l, 10 trials). There was no significant difference in mortality (0.90, 0.48 to 1.67, five trials). CONCLUSIONS: There is insufficient evidence to support or refute the use of non-absorbable disaccharides for hepatic encephalopathy. Antibiotics were superior to non-absorbable disaccharides in improving hepatic encephalopathy, but it is unclear whether this difference is clinically important. Non-absorbable disaccharides should not serve as comparator in randomised trials on hepatic encephalopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Self-citationWhat is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Oxford textbook of clinical hepatology
(2000) · Digestive and Liver Disease · doi:10.1016/s1590-8658(00)80409-0 · Cited by 697
Conn, H. O., Leevy, C. M., Vlahcevic, Z. R., Rodgers, J. B., Maddrey, W. C., Seeff, L. B., & Levy, L. L. (1977) · PubMed · Cited by 641
Shawcross, D. L., Davies, N. A., Williams, R., & Jalan, R. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.016 · Cited by 539
Blei, A. T., & Córdoba, J. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03964.x · Cited by 527
QUOROM Group, Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01610.x · Cited by 416
Kircheis, G., Nilius, R., Held, C., Berndt, H., Buchner, M., Gortelmeyer, R., Hendricks, R., Kruger, B., Kuklinski, B., Meister, H., et al. (1997) · Hepatology · doi:10.1002/hep.510250609 · Cited by 318
The Hepatic Coma Syndromes and Lactulose
Conn, H. O., Lieberthal, M. M., & Mandell, H. N. (1980) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198006000-00023 · Cited by 296
Atterbury, C. E., Maddrey, W. C., & Conn, H. O. (1978) · The American Journal of Digestive Diseases · doi:10.1007/bf01072921 · Cited by 263
Mas, A., Rodés, J., Sunyer, L., Rodrigo, L., Planas, R., Vargas, V., Castells, L., Rodrı́guez-Martı́nez, D., Fernández-Rodrı́guez, C., Coll, I., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00350-1 · Cited by 256
Watanabe, A., Sakai, T., Sato, S., Imai, F., Ohto, M., Arakawa, Y., Toda, G., Kobayashi, K., Muto, Y., Tsujii, T., et al. (1997) · Hepatology · doi:10.1002/hep.510260606 · Cited by 179
Lactulose in the Treatment of Chronic Portal-Systemic Encephalopathy: A Double-Blind Clinical Trial
Elkington, S. G., Floch, M. H., & Conn, H. O. (1969) · New England Journal of Medicine · doi:10.1056/nejm196908212810803 · Cited by 176
Stauch, S., Kircheis, G., Adler, G., Beckh, K., Ditschuneit, H., Görtelmeyer, R., Hendricks, R., Heuser, A., Karoff, C., Malfertheiner, P., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80237-7 · Cited by 169
Treatment of chronic portal-systemic encephalopathy with lactulose
Bircher, J., Haemmerli, U. P., Scollo‐Lavizzari, G., & Hoffmann, K. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90233-6 · Cited by 163
TREATMENT OF CHRONIC PORTAL-SYSTEMIC ENCEPHALOPATHY WITH LACTULOSE
Müller, J. B., Guggenheim, P., & Haemmerli, U. P. (1966) · The Lancet · doi:10.1016/s0140-6736(66)91573-x · Cited by 163
Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy
Dhiman, R. K., Sawhney, I. M. S., Chawla, Y. K., Das, G. C., Ram, S., & Dilawari, J. B. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005556826152 · Cited by 140
Strauss, E., Tramote, R., Silva, E. P., Caly, W. R., Honain, N. Z., Maffei, R. A., & de Sá, M. D. F. G. (1992) · PubMed · Cited by 136
Bucci, L., & Palmieri, G. C. (1993) · Current Medical Research and Opinion · doi:10.1185/03007999309111539 · Cited by 131
Olde Damink, S. W. M., Jalan, R., Deutz, N. E. P., Redhead, D. N., Dejong, C. H. C., Hynd, P., Jalan, R. A., Hayes, P. C., & Soeters, P. B. (2003) · Hepatology · doi:10.1053/jhep.2003.50221 · Cited by 123
NEOMYCIN IN THE TREATMENT OF HEPATIC COMA
Dawson, A. H. (1957) · The Lancet · doi:10.1016/s0140-6736(57)91544-1 · Cited by 123
Morgan, M. Y., & Hawley, K. E. (1987) · Hepatology · doi:10.1002/hep.1840070617 · Cited by 118
Nonabsorbable disaccharides for hepatic encephalopathy
Als-Nielsen, B., Gluud, L. L., & Gluud, C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003044.pub2 · Cited by 117
Self-citationLactitol or lactulose in the treatment of chronic hepatic encephalopathy: Results of a meta-analysis
Blanc, P., Daurès, J., Rouillon, J.-M., Fabbro-Péray, P., Pierrugues, R., Larrey, D. G., Grémy, F., & Michel, H. (1992) · Hepatology · doi:10.1002/hep.1840150209 · Cited by 87
Lactitol in treatment of chronic hepatic encephalopathy: A meta-analysis
Cammà, C., Fiorello, F., Tin�, F., Marchesini, G., Fabbri, A., & Pagliaro, L. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01295920 · Cited by 84
Festi, D., Mazzella, G., Orsini, M., Sottili, S., Sangermano, A., Bassi, S. L., Parini, P., Ferrieri, A., Falcucci, M., Grossi, L., et al. (1993) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80681-2 · Cited by 75
Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy
Orlandi, F., Freddara, U., Candelaresi, M. T., Morettini, A., Corazza, G. R., Simone, A. D., Dobrilla, G., & Cavallini, G. (1981) · Digestive Diseases and Sciences · doi:10.1007/bf01308097 · Cited by 67
Loguercio, C., Federico, A., Girolamo, V. D., Ferrieri, A., & Blanco, C. D. V. (2003) · PubMed · Cited by 63
Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy
Morgan, M. Y., Hawley, K. E., & Stambuk, D. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80086-7 · Cited by 58
Blanc, P., Daurès, J., Liautard, J., Buttigieg, R., Desprez, D., Pageaux, G.-P., Allaz, J.-L., Parelon, G., Larrey, D. G., & Michel, H. (1994) · PubMed · Cited by 55
Rifaximin in the treatment of chronic hepatic encephalopathy
Puxeddu, A., Quartini, M., Massimetti, A., & Ferrieri, A. (1995) · Current Medical Research and Opinion · doi:10.1185/03007999509111552 · Cited by 53
Hepatic encephalopathy in cattle.
Finn, J. P., & Tennant, B. (1974) · PubMed · Cited by 48
Minimal hepatic encephalopathy: A permanent source of discussion
Weißenborn, K. (2002) · Hepatology · doi:10.1053/jhep.2002.31552 · Cited by 47
Use of the equivalence approach in reproductive health clinical trials
Piaggio, G., & Pinol, A. P. Y. (2001) · Statistics in Medicine · doi:10.1002/sim.1078 · Cited by 38
Nutritional Aspects of Liver and Biliary Disease
Campillo, B. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch23b · Cited by 4
Cited by
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K. D., Weissenborn, K., & Wong, P. (2014) · Hepatology · doi:10.1002/hep.27210 · Cited by 2,056
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Bias in clinical intervention research.
Gluud, L. L. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj069 · Cited by 636
Self-citationPrasad, S., Dhiman, R. K., Duseja, A., Chawla, Y. K., Sharma, A., & Agarwal, R. (2007) · Hepatology · doi:10.1002/hep.21533 · Cited by 601
Metadata
- Authors
- Als-Nielsen, B., Gluud, L. L., & Gluud, C.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2004-03-30
- Volume
- 328
- Issue
- 7447
- Pages
- 1046
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2135051122
- Cited by
- 371
- References
- 41
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.